Mizuho analysts increased their price target on Amylyx Pharmaceuticals, with the news being reported by Benzinga on July 20, 2026.
5 reports, 2 independent
Updated Sat 00:00
No new developments lately
- Reports
- 5
- Developments
- 2
- Repetition
- 60%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Mizuho analysts increased their price target on Amylyx Pharmaceuticals, with the news being reported by Benzinga on July 20, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Citigroup raised its price objective for Amylyx Pharmaceuticals, alongside MarketBeat consensus ratings.1 source
Mizuho raised target price on Amylyx Pharmaceuticals; Benzinga reported the stock analysis.1 source
Keep exploring
The entities involved
-
Amylyx Pharmaceuticals
American biopharmaceutical company
Nothing else this week.
-
Mizuho
city in Gifu prefecture, Japan
-
Benzinga
American news channel
Related events
- Benzinga reported that Mizuho cut its target price for a stock.
- Mizuho, Bank of America, and TD Cowen have issued rating and price target changes for Texas Instruments.
- Benzinga Pro data reports on stock activity for Webull, a company related to the Nasdaq exchange.
- Keefe, Bruyette & Woods lifted its price target, and Mizuho dropped its target price on Prudential plc stock.
- Benzinga reported on the earnings of Penguin Solutions.